Skip to content
Search

Latest Stories

Pharmacy Business Diversity Conference - session summary: 'More needs to be done for inclusion of LGBTQ in workplace

There is a great scope of improvement regarding the inclusion of LGBTQ people in the pharmaceutical sector, panelists said at the Pharmacy Business Diversity Conference during a session on LGBTQ+ Inclusion in the Workplace.

Robbie Turner, director of pharmacy and member experience at the Royal Pharmaceutical Society (RPS), sharing his feedback from others in the profession, said “this wasn't a profession that was welcoming of difference,” adding “the sector needs to improve in this regard.”


Turner, who came out as a gay man at 15 and have been out (openly gay) at work ever since, acknowledged that despite being a senior leader he faces microagression.

“I don't suffer from homophobia, but I do suffer from microaggression even as a senior leader, often from people who are being perfectly nice."

Robbie, who recently adopted two children said people often ask him, “what's the children's mother called? What does your wife do?”.

It is important to “use more open and inclusive language without being detrimental to anybody."

Turner noted that in efforts towards inclusion of LGBTQ+, it is crucial to encourage open conversations about microaggressions and bringing people together to share their experiences of life, he said.

Further, he said that RPS is creating an umbrella network for cultural diversity, “making things better for any group, who feels marginalised. It is going to be helpful for everybody and makes workplaces better.”

“We celebrate people's difference and recognise the benefits in pharmacy.”

The session, moderated by the conference chair BBC presenter Clive Myrie, also had Annie Newman, senior digital content editor at GSK and Bhavik Pancholi, senior manager Diversity & Inclusion at Mundipharma.

Talking about initiatives to promote inclusion at GSK, Newman said the company often shares stories, “letting people know what it's like to work with the GSK as an LGBTQ+ person.”

At GSK there are areas where LGBTQ+ can actively take part and see senior leaders talking about what it's like to be from that group and have mentors from the community to help them feel inclusive, she said.

Besides storytelling the company does “a lot in the background that isn't always visible to employees.”

She added the firm has been working to alter its recruitment process to make it more inclusive like having a diverse recruitment panel, advertising at places where more LGBTQ+ women work.

Also, the company emphasises on using inclusive language in its policies.

Putting more weight behind having open conversations, Pancholi said it is important to speak with the LGBTQ+ community and understand their experiences rather than making assumptions about them.

He said: “Let's remember there are people outside the binary of male and female, so if we don't have a voice, let's still make sure that we are inclusive in the language that we use.”

He added that there are several ways in which allies can show their support towards the LGBTQ+ community for example by including them on their email signatures and by ensuring a safe workplace.

“I think it's important to recognize at work, as having a safe workplace is often a haven for people because life isn't safe.

“Homophobia is on the increase, transphobia is rampant, so people should be able to come to work and feel as safe and as welcome and celebrated as possible."

More For You

Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less